Epicenters for the Prevention of Healthcare Associated Infections, Antimicrobial Resistance and Adverse Events

Funding Opportunity Number: CDC-RFA-CK16-004
Opportunity Category: Discretionary
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Health
CFDA Number: 93.084
Eligible Applicants Others (see text field entitled “Additional Information on Eligibility” for clarification)
Agency Name: HHS-CDC
Closing Date: Jan 15, 2016
Award Ceiling: $500,000
Expected Number of Awards: 5
Creation Date: Oct 30, 2015
Funding Opportunity Description: The purpose of this Funding Opportunity Announcement (FOA) is to support the translation of basic, epidemiologic and technologic discoveries into new strategies for preventing and decreasing the incidence of healthcare-associated infections (HAIs), antimicrobial resistance (AR) and other adverse events in all types of healthcare facilities in the United States. CDC is interested in building upon research gains accomplished under FOA CK11-001: Epi-Centers for the Prevention of Healthcare-Associated Infections, Antimicrobial Resistance and Adverse Events over the past 5 years

Source:: http://www.grants.gov/web/grants/view-opportunity.html?oppId=279911


Please enter your comment!
Please enter your name here